Dermot Mark Durcan's most recent trade in Cencora Inc. was a trade of 986 Common Stock done . Disclosure was reported to the exchange on March 6, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Cencora Inc. | Dermot Mark Durcan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 986 | 22,862 (0%) | 0% | - | Common Stock | |
Cencora Inc. | Dermot Mark Durcan | Director | Purchase of securities on an exchange or from another person at price $ 218.58 per share. | 24 May 2024 | 500 | 21,876 (0%) | 0% | 218.6 | 109,290 | Common Stock |
Advanced Micro Devices Inc. | Dermot Mark Durcan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 1,547 | 1,547 | - | - | RSU Award | |
Cencora Inc. | Dermot Mark Durcan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2024 | 1,593 | 0 | - | - | Restricted Stock Units | |
Cencora Inc. | Dermot Mark Durcan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2024 | 1,593 | 20,323 (0%) | 0% | - | Common Stock | |
Cencora Inc. | Dermot Mark Durcan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2024 | 1,053 | 21,376 (0%) | 0% | - | Common Stock | |
Advanced Micro Devices Inc. | Dermot Mark Durcan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 2,709 | 2,709 | - | - | RSU Award | |
Cencora Inc. | Dermot Mark Durcan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2023 | 1,667 | 18,730 (0%) | 0% | - | Common Stock | |
Cencora Inc. | Dermot Mark Durcan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2023 | 2,012 | 0 | - | - | Restricted Stock Units | |
Cencora Inc. | Dermot Mark Durcan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2023 | 2,012 | 14,272 (0%) | 0% | - | Common Stock | |
Advanced Micro Devices Inc. | Dermot Mark Durcan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 2,197 | 2,197 | - | - | RSU Award | |
Cencora Inc. | Dermot Mark Durcan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 1,197 | 1,197 | - | - | Restricted Stock Units | |
Cencora Inc. | Dermot Mark Durcan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2022 | 2,101 | 0 | - | - | Restricted Stock Units | |
Cencora Inc. | Dermot Mark Durcan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2022 | 2,101 | 12,260 (0%) | 0% | - | Common Stock | |
Cencora Inc. | Dermot Mark Durcan | Director | Grant, award, or other acquisition of securities at price $ 96.07 per share. | 02 Nov 2020 | 325 | 7,716 (0%) | 0% | 96.1 | 31,223 | Common Stock |
Cencora Inc. | Dermot Mark Durcan | Director | Grant, award, or other acquisition of securities at price $ 100.19 per share. | 03 Aug 2020 | 312 | 7,391 (0%) | 0% | 100.2 | 31,259 | Common Stock |